Nigeria News API

{
    "totalArticles": 19936,
    "articles": [
        {
            "id": "495f673a9ab20894e02b7a2309f458a9",
            "title": "Judge Warns Lawyers In Malami Case Against Influence Campaign",
            "description": "In a related development, Justice Emeka Nwite warns parties in the ongoing trial of the former Minister of Justice Abubakar Malami and two",
            "content": "In a related development, Justice Emeka Nwite warns parties in the ongoing trial of the former Minister of Justice Abubakar Malami and two others not to approach him seeking any form of influence.\nJustice Nwite made his statement after delivering his... [703 chars]",
            "url": "https://www.tvcnews.tv/judge-warns-lawyers-in-malami-case-against-influence-campaign/",
            "image": "https://www.tvcnews.tv/wp-content/uploads/2026/01/Screenshot-2026-01-07-105505.png",
            "publishedAt": "2026-01-07T09:53:00Z",
            "lang": "en",
            "source": {
                "id": "874bdd66b5299e79a3c1e6ff1fc005e9",
                "name": "TVC News",
                "url": "https://www.tvcnews.tv"
            }
        },
        {
            "id": "16b9420ead1378b0fc6ab1c31f13470e",
            "title": "How Delcy Rodríguez courted Donald Trump and rose to power in Venezuela",
            "description": "Delcy Rodríguez, Venezuela's interim president, has risen to prominence through strategic moves and political savvy",
            "content": "MIAMI -- In 2017, as political outsider Donald Trump headed to Washington, Delcy Rodríguez spotted an opening.\nThen Venezuela's foreign minister, Rodríguez directed Citgo — a subsidiary of the state oil company — to make a $500,000 donation to the pr... [7790 chars]",
            "url": "https://abcnews.go.com/Business/wireStory/delcy-rodrguez-courted-donald-trump-rose-power-venezuela-128961510",
            "image": "https://i.abcnewsfe.com/a/fd51300b-1b6a-4b18-b785-8c4cf16fd482/wirestory_e71f2289bc801446e05550d8f900a8d1_16x9.jpg?w=1600",
            "publishedAt": "2026-01-07T07:50:58Z",
            "lang": "en",
            "source": {
                "id": "5ca536331c246cd7f693cdb2cceaff8c",
                "name": "ABC News",
                "url": "https://abcnews.go.com"
            }
        },
        {
            "id": "dc9766db9c9f72eea12dcf9a30623751",
            "title": "GSK announces positive results from B-Well 1 and B-Well 2 phase III trials for bepirovirsen, a potential first-in-class treatment for chronic hepatitis B",
            "description": "Bepirovirsen demonstrated a statistically significant and clinically meaningful functional cure rate",
            "content": "Primary endpoint met in both trials\nBepirovirsen demonstrated a statistically significant and clinically meaningful functional cure rate\nChronic hepatitis B (CHB) accounts for ~56% of liver cancer cases 1 and affects more than 250 million people worl... [5603 chars]",
            "url": "https://www.gsk.com/en-gb/media/press-releases/gsk-announces-positive-results-from-b-well-1-and-b-well-2-phase-iii-trials-for-bepirovirsen-a-potential-first-in-class-treatment-for-chronic-hepatitis-b/",
            "image": "https://www.gsk.com/media/p3clrlre/stvg_2_2022_smtlab_17_hess.jpg?width=600&format=webp&quality=100&v=1dbd496701ca530",
            "publishedAt": "2026-01-07T07:10:36Z",
            "lang": "en",
            "source": {
                "id": "641839a32c164b57ea83cee10995961f",
                "name": "GSK",
                "url": "https://www.gsk.com"
            }
        }
    ]
}